Current diagnosis and management of medullary thyroid carcinoma-Reference-Cited by-同舟云学术

Current diagnosis and management of medullary thyroid carcinoma

Published:1998-07 Issue:7 Volume:9 Page:695-701
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Giuffrida Dario,Gharib Hossein

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/9/7/695/19482110/9-7-695.pdf

Reference63 articles.

1. Medullary (solid) carcinoma of the thyroid – a clinicopathologic entity;Hazard;J Clin Endocrinol Metab,1959

2. Medullary thyroid carcinoma: Clinicopathologic features and long-term follow-up of 65 patients treated during 1946 through 1970;Gharib;Mayo Clin Proc,1992

3. Medullary thyroid carcinoma: Recent advances and management update;Marsh;Thyroid,1995

4. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC;Mulligan;Nat Genet,1994

5. Identification of multiple endocrine neoplasia, type 2 gene carriers using linkage analysis and analysis of the RET proto-oncogene;Tsai;J Clin Endocrinol Metab,1994

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive and prognostic value of aurora kinase A combined with tumor-infiltrating lymphocytes in medullary thyroid carcinoma;Frontiers in Oncology;2024-06-06

2. Strategies for Treatment of Thyroid Cancer;Current Drug Targets;2023-04

3. The role of external beam radiation therapy in the management of thyroid carcinomas: A retrospective study in Iran Cancer Institute;Cancer Reports;2022-06-12

4. Development and Validation of a Nomogram for Predicting Survival in Patients with Thyroid Cancer;Medical Science Monitor;2019-07-27

5. MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma;Biomedicine & Pharmacotherapy;2019-02